Evaluation of the effectiveness of sarcosine to parental education management treatment on the symptoms of coping disorder
Early Phase 1
- Conditions
- Oppositional Defiant Disorder.F91/3
- Registration Number
- IRCT20211022052836N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
1. Girl and boy children aged 6 to 12 years who have been diagnosed with coping disorder by a psychiatrist based on the DSM-V. 2. Parents' consent to participate in the study
Exclusion Criteria
1- Patients who do not want to continue participating in the study at any stage. 2- Patients who do not plan their medication according to the prescribed medication and do not take it accurately. 3- Patients for whom another diagnosis is made during the study.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of people with Oppositional Defiant Disorder. Timepoint: At the beginning of the study, 2, 6 and 12 weeks after treatment. Method of measurement: Inventory Oppositional defiant behavioral Questionnaire (ODBI) and Demographic Information Questionnaire.
- Secondary Outcome Measures
Name Time Method